Hydroxychloroquine and remdesivir not effective in covid-19 treatment: WHO

Posted on 17th Oct 2020 03:29 pm by rohit kumar

The World Health Organization has identified four drugs, including remadecivir and hydroxychloroquine (HCQ), to be much less effective in treating corona virus-infected patients.


The World Health Organization (WHO) conducted a detailed test on how effective four particular drugs are in the treatment of Covid-19.


Remadecivir was the first drug that was first used to treat the coronavirus. This drug was also recently used in the treatment of US President Donald Trump.


Gilead, the maker of Remedesivir, has rejected the results of the WHO study.


Gilead issued a statement saying that the findings of the study do not match those of other studies and these results are yet to be reviewed.




The WHO tested a total of four drugs during the Solidarity trial. Including remdesivir , hydroxychloroquine, auto-immune drug interferon, and a combination of HIV drugs lopinavir and ritonavir.


The low-cost steroid dexamethasone used in the treatment of severe Covid-19 patients in Britain has not been included in this study.


These four drugs were tested in 11,266 adult patients in 500 hospitals in 30 different countries.


WHO results have found that these drugs have not proved effective in saving patients' lives and also reducing the days of infection. However, these results are yet to be reviewed.


WHO Chief Scientist Soumya Swaminathan said on Wednesday that the testing of hydroxychloroquine and lopinavir and ritonavir was stopped in June as they had already proved ineffective. However, tests on other drugs were continued.


The results of the World Health Organization are completely different from the results of Gilead's study last month. Gilead had said that the time to recover from comrades virus is reduced by five days compared to patients given placebo. Gilead's trial involved 1000 patients.


Gilead's response


Gilead Sciences has dismissed the WHO results, saying, "This data looks inconsistent." The benefits of remdesivir are evidenced by more concrete evidence from academic and controlled studies published in several journals.


"We are concerned that this open (open) labeled global test data has not gone through rigorous review, which is necessary for such useful scientific discussion."


In the United States, the use of remdesivir has been allowed in an emergency from May 1. After this, its use was also approved in many other countries.


At the same time, hydroxychloroquine is used on the instructions of the doctor to protect against coronavirus infection. However, there is no clear evidence of how effective it is.


Looking at these results, Dr. Swaminathan says, "We are considering monoclonal antibodies and some new anti-viral drugs that have been developed in the last few months."

1 Like 0 Dislike
Previous news Next news
Other news

100 Tripura students fall ill after taking deworming tablets

Agartala, Feb 11 (IANS) Around 100 school students in Tripura fell ill Wednesday and were admit

iPhone 12 may be launched on this day, four new iPhones can be introduced under the series

San Francisco: Apple can launch its most awaited series iPhone 12 on 13 October. According to a r

Respond to AAP's posters removal complaint: HC to government

New Delhi, Jan 6 (IANS) The Delhi High Court Tuesday asked the city government to respond to a

US channel claims: China created corona virus in Wuhan's lab with 'special purpose'

Ever since the global pandemic corona virus spread across the world, questions have been raised a

Patients crossed the 40 lakh mark, a record 87 thousand 115 cases were found in 24 hours, 69 thousand people were cured; So far, 69 thousand 635 deaths in the country

The figure of Corona patients in the country crossed 40 lakh on Friday. So far, 40 lakh 17 thousa

Sign up to write
Sign up now if you have flare of writing..
Login   |   Register
Follow Us
Indyaspeak @ Facebook Indyaspeak @ Twitter Indyaspeak @ Pinterest RSS

Play Free Quiz and Win Cash